PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP
PFID 805-5703280361
Managed by AISLING CAPITAL LLC
Venture Capital Fund 3(c)(7) Master Fund
Gross Asset Value
$68M
Min. Investment
$10,000,000
Investors
16
First Sale
--
FY End
--
Service Providers
Auditor
COHNREZNICK LLP
NEW YORK, New York, United States
PCAOB: Registered
Independent: Yes
Custodian
HSBC BANK USA NA
NEW YORK, New York, United States
Administrator
SS&C, INC.
NEW YORK, New York, United States
Fund Details
- Fund Type
- Venture Capital Fund
- State Organized
- Delaware
- Owned by Adviser
- 10.0%
- Annually Audited
- Yes